期刊文献+

SV40灭活疫苗免疫恒河猴后的抗体反应

Antibody Response Induced by Inactivated SV40 Vaccine in Macaques
下载PDF
导出
摘要 目的 评价SV40灭活疫苗免疫恒河猴后的抗体反应.方法 用SV40灭活疫苗经肌肉注射免疫0.5~1周岁的恒河猴,分别于第1次和第2次免疫后2周,检测血清中和抗体效价,免疫18个月后检测SV40基因组成分.结果 免疫的12只恒河猴在第1次免疫后2周,血清抗体全部阳转,平均抗体滴度为1:16,第2次免疫2周后血清抗体滴度明显增长,平均达到1:64~1:128.用PCR方法未检测到SV40基因组成分.结论 SV40灭活疫苗可以有效诱导恒河猴产生特异性抗体反应. Objective To evaluate the antibody response induced by inactivated SV40 vaccine in macaques. Methods Immunize macaques aged 6 - 12 months by intramuscular injection with inactivated SV40 vaccine for 2 times, at an interval of 10 weeks. Collect the venous blood 2 months after the 1st and the 2nd immunization respectively for determination of serum neutralizing antibody titer,and the peripheral blood 18 months after the 2nd immunization for SV40 genomic component. Results The serum antibody positive conversion rate of all the 12 macaques 2 weeks after the 1st immunization was 100% ,and the mean antibody titer was 1: 16. However,the mean antibody titer 2 weeks after the 2nd immunization reached 1:64 - 1: 128. No SV40 genomic component was detected by PCR in the peripheral blood of macaques 18 months after the 2nd immunization. Conclusion Inactivated SV40 vaccine induced specific antibody response in macaques.
出处 《中国生物制品学杂志》 CAS CSCD 2007年第9期664-666,共3页 Chinese Journal of Biologicals
基金 云南省自然科学基金(2003C077M)资助项目
关键词 猴空泡病毒40 灭活疫苗 恒河猴 抗体反应 Simian vacuolation virus 40(SV40) Inactivated vaccine Macaque Antibody response
  • 相关文献

参考文献3

  • 1曹增,孙强明,孙娟,蒋鸿超,李洪钊,谢天宏,孙茂盛,戴长柏.SV40灭活疫苗的制备及其对小鼠免疫的研究[J].中国病毒学,2005,20(2):159-163. 被引量:4
  • 2Lelie PN,Reesink HW,Lucas CJ.Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine.J Med Virol,1987,23(3):297-301.
  • 3Budowsky EI,Friedman EA,Zheleznova NV,et al.Principles of selective inactivation of viral genome.VI.Inactivation of the infectivity of the influenza virus by the action of β-propiolactone.Vaccine,1991,9(6):398-402.

二级参考文献19

  • 1Shah K, Nathanson N. Human exposure to SV40: review and comment [J] .Am J Epidemiol, 1976,103:1 -12.
  • 2Watts A M, Bright R K, Kennedy R C. DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model[J]. Dev Biol (Basel), 2000,104:143-147.
  • 3Kennedy R C, Shearer M H, Watts A M, et al. CD4+ T Lymphocytes Play a Critical Role in Antibody Production and Tumor Immunity against Simian Virus 40 Large Tumor Antigen [J]. Cancer Res, 2003, 63: 1040 - 1045.
  • 4Brian W J, Hillar M, Kangro O. Virology Methods Manual [M]. San Diego: ACADEMIC PRESS INC, 1996.
  • 5Laakkonen P, Hyvonen M, Peranen J, et al. Expression of SemLiki Forest virus nsP1-specific methyltransferase in insect cells and in Escherichia coli [J]. J Virol, 1994, 68:7418-7425.
  • 6Johansen K, Schroder U, Svensson L. Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants [J]. Vaccine, 2003, 21: 368-375.
  • 7Power U F, Plotnicky H, Blaecke A, et al. The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B [J]. Vaccine, 2003, 22: 168-176.
  • 8Edevag G, Grandien M, Mares I. An enzyme-linked immunosorbent assay, ELISA, for SV40 antigen detection [J]. J Virol Methods, 1985, 11: 347-355.
  • 9Minor P, Pipkin P, Jarzebek Z, et al. Studies of neutralising antibodies to SV40 in human sera [J]. J Med Virol, 2003, 70: 490-495.
  • 10Strickler H D. International SV40 Working Group A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens [J]. Cancer Epidemiol Biomarkers Prev, 2001, 10: 523-532.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部